Skip to main content

[New post] Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer

Daniel Webster posted: " HOUSTON--(BUSINESS WIRE)--ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr. Revati Shreeniwas has joined the company as Chi"

Comments

Popular posts from this blog

[New post] Changes in how cholesterol breaks down in the body may accelerate progression of dementia

[New post] Entertainment: You Season 3 Finally Gets Release Date: See the Bloody Announcement

The biggest controversy surrounding Apple’s new iPad Pro isn’t actually an issue at all